Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MRI Derived Quantitative Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

NCT03585660 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT03585660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03585660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MRI Derived Quantitative Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
Lead sponsor
University of Chicago
Phase
Not applicable
Overall status
Completed
Start date
August 28, 2018
Completion date
November 6, 2023
Enrollment
106 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer